spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

 

For further information please contact:

Advertising
Jonathan Smith

Editorial
Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


View the digital version of EPC




 

epc
 
 
Featured in this issue
Science & Innovation: Cancer Focus
Phase 1 Oncology Trials

Lessons Learned


New challenges are arising with the growing number and size of Phase 1 oncology trials. Sean Hart at Vector Oncology and Rabinder Buttar at ClinTec International share the best ways to optimise study outcomes.
Labs & Logistics
Laboratory Relocation

The Right Move


Potential research disruption, damage to samples and heavy costs can strike fear into any company considering a laboratory move. John Best at Andrew Porter Ltd tells us how to make a success of any relocation.
  Data Management & IT Solutions
Cloud-Based Compliance Software

Secure Environment


Constantly validated, secure data can be achieved through cloud-based compliance systems. However, several myths surround their implementation – James Brown of Zinc Ahead explains why these can be cast aside.

spacer
Edited by
Dr Graham Hughes,
Consultant in
Pharmaceutical
Development
Published quarterly in
March, June,
September and December
Banner of PCI.EPC on Samedan
Banner of Samedan app.EPC on Samedan
Banner of Woodley.EPC on Samedan
 
Industry Events

CPhI Worldwide

7-9 October 2014, Paris Nord Villepinte, France

CPhI Worldwide, together with co-located events ICSE, InnoPack, and P-MEC, offers products and services catered to specific sectors of the pharmaceutical manufacturing market, covering the entire supply chain. The expanded exhibition makes the event the most effective and efficient place to make valuable business connections.
More info >>

 
News and Press Releases

Woodley Equipment is Exhibiting at Outsourcing in Clinical Trials New England

Woodley Equipment a specialist global supplier of medical and laboratory equipment to the Clinical Trials industry is exhibiting at Outsourcing in Clinical Trials New England taking place at The Westin Boston Waterfront Hotel, Boston, MA from 7th to 8th October 2014. 
More info >>

air transport logo

 

White Papers

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement